iPremom
Last verified 2026-05-02. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $39.5Mattributed |
|---|---|
| Latest round | grant, $2.7M, 2026-04-01attributed |
| Founded | unknown |
| Headquarters | Paterna, Valencia, Spain |
| Industry | medtech |
| Stage | unknown |
| Website | ipremom.com |
iPremom develops molecular blood tests for early diagnosis of pregnancy complications such as preeclampsia. It targets clinicians and expectant mothers needing early risk detection. Its differentiator is analyzing thousands of circulating molecules to flag risk before symptoms appear.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-04-01 | grant | $2.7M | undisclosed |
Detected tech stack
LiteSpeed, WordPress 6.9.4, LiteSpeed Cache, Google Analytics, Google Tag Manager, jQuery Migrate 3.4.1, imagesLoaded 4.1.4, PHP, Plesk, DoubleClick Floodlight, Contact Form 7 6.1.5, CookieYes
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $2.7M | attributed | eu-grant named as publisher. No document URL on file. |
| Total raised $39.5M | attributed | eu-grant named as publisher. No document URL on file. |
| Company existence | self-reported | ipremom.com, read 2026-05-02 |
| Description | self-reported | ipremom.com, read 2026-05-02 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.